Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Fotemustine

Home Drugs福莫司汀

Investigational

Small Molecule

福莫司汀

Unknown Manufacturer • 原发性脑内肿瘤和播散性恶性黑色素瘤（包括脑内部位）。

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Overview

Fotemustine is an alkylating agent used in the treatment of metastatic melanoma.

Associated Conditions

Metastatic Melanoma

Chemical Formula

C<sub>9</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>5</sub>P

CAS Number

92118-27-9

UNII ID

GQ7JL9P5I2

Indication

原发性脑内肿瘤和播散性恶性黑色素瘤（包括脑内部位）。